Immunity restoration of immunity with interleukin-2 therapy

AIDS Reader

Volumn 9, Issue 8, 1999, Pages 563-572

  Smith, K A ^a   Jacobson, E L ^a   Emert, R ^a   Giordano, M ^a   Kovacs, E ^a   Mumneh, N ^a   Pilaro, F ^a   Sohn, T ^a   Warren, D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytokine; HIV; Immunotherapy; Interleukin 2 (IL 2)

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HELPER CELL; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NATURAL KILLER CELL; T LYMPHOCYTE SUBPOPULATION; VIRUS LATENCY; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; IMMUNOTHERAPY; REVIEW;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS, NATURAL; RECEPTORS, INTERLEUKIN-2; VIRUS LATENCY;

EID: 0033222715     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)